Introduction
The benzimidazole nucleus is a useful structure for research and development of new pharmaceutical molecules. Benzimidazole are among the important heterocyclic compounds found in several natural and non-natural products such as Vitamin B12 [1] , marine alkaloid kealiiquinone [2] , benzimidazole nucleosides [3, 4] etc. Some of their derivatives are marketed as anti-fungal [5] , anti-helmintic [6, 7] and antipsychotic [8, 9] drugs and other derivatives have been found to possess some interesting bioactivities such as anti-tubercular [10] , anti-cancer [11, 12] , HIV-inhibitors [13] , anti-hypertensive agent [14] , anti-inflammatory activity [15] , anti-allergic activity [16] , anti-diabetic activity [17] , anticonvulsant activity [18] , DNA inhibitory activity [19] etc. We have also published some series of biologically active benzimidazoles [20] . Owing to the immense biological importance of benzimidazole derivatives, we now synthesized some novel class of benzimidazole derivatives and their biological activity screening studies.
Experimental

Chemicals
Phenylboronic acid, 4-ethyl phenylboronic acid, palladium acetate, potassium fluoride and 18-crown-6 ether obtained from Aldrich. o-Phenylenediamine, 4-bromophenoxy acetic acid, alkylating agents and sodium hydride were obtained from commercial suppliers. All the solvents used were of commercial grade only.
Instrumentations
Melting points recorded on a MRVIS Series, Lab. India Instrument. TLC analysis was done using pre-coated silica gel plates and visualization was done using iodine/UV lamp. Infrared spectra were recorded on Perkin Elmer model FT-IR using the KBr disc. 1 To a solution of 4-bromophenoxy acetic acid (2) (10.8 g, 50 mmol) and 4 N HCl (50 mL), o-phenylenediamine (1) (5.40 g, 50 mmol) was added. The reaction mixture was heated slowly to reflux temperature for 6 hours (TLC monitoring). The reaction mixture was then cooled to room temperature and neutralized with 10% aq. NaHCO3 till the neutral pH. The reaction mixture was stirred for 30 min resulted free flowing suspension. The solid separated out was filtered, washed with water (3 × 30 mL) and dried under vacuum to afford an offwhite solid. The crude product was recrystallized from hot aq. ethanol to obtain the pure white crystalline compound 3 (Scheme 1). Yield: 13.5 g, 89 %. M.p.: 260-262 °C (Lit. [22] : 260 °C).
Synthesis of compound 3 via microwave irradiation
To a solution of 4-bromophenoxy acetic acid (2) (10.8 g, 50 mmol) and 4 N HCl (50 mL), o-phenylenediamine (1) (5.40 g, 50 mmol) was added. The reaction mixture was irradiated in a microwave oven at 100 W for 3 min at 100 °C. The reaction mixture was then cooled to room temperature and neutralized with aq. NaHCO3 (10%) till the neutral pH. The reaction mixture was stirred for 30 min resulted free flowing suspension. The solid separated out was filtered, washed with water (3 × 30 mL) and dried under vacuum to afford an offwhite solid. The crude product was recrystallized from hot aq. ethanol to obtain the pure white crystalline compound 3. Yield: 13.0 g, 87%. M.p.: 260-262 °C (Lit. [22] : 260 °C). To a solution of 2-(4-bromo-phenoxymethyl)-1H-benzimidazole (2 mmol) (3) in dimethylformamide (10 mL) was added sodium hydride (60 %, 2.4 mmol) lot wise at 0 °C. After completion of addition, the temperature of the reaction mixture was slowly raised to room temperature and stirred at this temperature for 1 h. The reaction mixture was again cooled to 0 °C and the respective alkyl halide (2.4 mmol) was added at 0 °C. The temperature of the reaction mixture was then allowed to warm to room temperature and stirred for 2 h.
After completion of the reaction, (TLC monitoring) water (50 mL) was slowly added to reaction mixture and extracted with ethyl acetate (2 × 25 mL). The organic layer was washed with water (2 × 25 mL), brine and dried over anhydrous sodium sulfate and concentrated under vacuum to yield the corresponding N-substituted derivatives (4a-g) the crude compounds were recrystallized from hot aq. ethanol to obtain pure products. Scheme 1.
General procedure for the synthesis of Suzuki coupling [24-26] compounds 5a-n
To a solution of N-alkylated benzimidazole compounds 4a-g (2.5 mmol) in toluene (50 mL) was added phenylboronic acid and 4-ethylphenylboronic acid (3 mmol), presence of potassium fluoride (5 mmol), 18-crown-6 ether (1.25 mmol) and palladium acetate (0.125 mmol). The reaction mixture was then refluxed and maintained for 3 h (TLC monitored). Upon completion, reaction mixture was allowed to cool to room temperature and filtered through hyflo. The toluene filtrate was washed with 5% NaHCO3 (25 mL), brine (25 mL) and water (25 L and dried over anhydrous sodium sulphate. Evaporation of the solvent yielded crude products, which were subjected to column chromatography to isolate the pure products 5a-n, Scheme 2.
Synthesis of Suzuki coupling compounds 5a-n via microwave irradiation
To a solution of N-alkylated benzimidazole compounds 4a-g (2.5 mmol) in toluene (50 mL) was added phenylboronic acid and 4-ethylphenylboronic acid (3 mmol), presence of potassium fluoride (5 mmol), 18-crown-6 ether (1.25 mmol) and palladium acetate (0.125 mmol) was heated under microwave conditions at 150 °C and 200 Watt for 2 minutes. It was allowed to cool to room temperature and filtered through hyflo. The toluene filtrate was washed with 5% NaHCO3 (25 mL), brine (25 mL) and water (25 mL) and dried over anhydrous sodium sulphate. Evaporation of the solvent yielded crude products, which were subjected to column chromatography to isolate the pure products 5a-n, Scheme 2. 5a  100  62.5  200  100  5b  125  100  62.5  200  5c  100  100  200  250  5d  62.5  100  125  250  5e  125  200  125  100  5f  250  100  250  125  5g  100  200  100  125  5h  100  100  250  250  5i  250  200  250  250  5j  250  125  100  250  5k  100  125  125  200  5l  200  250  250  500  5m  150  200  250 >1000  5b  >1000  500  500  5c  500  500  500  5d  >1000  >1000  >1000  5e  1000  250  500  5f  500  >1000  >1000  5g  1000  1000  1000  5h  250  500  500  5i  1000  250  250  5j  500  500  500  5k  1000  500  1000  5l  >1000  >1000  >1000  5m  >1000  >1000  >1000  5n  500  500  500  Nystatin  100  100  100  Greseofulvin  500  100 
2-(Biphenyl-4-yloxymethyl)-1-methyl-1H-benzoimidazole
2-(Biphenyl-4-yloxymethyl)-1-trifluoromethanesulfonyl-1H-
2-(4'-Ethyl-biphenyl-4-yloxymethyl)-1-methyl-1H-benzoimi dazole
Biological evaluation-antibacterial and antifungal activity studies
The microbial activity was undertaken to evaluate the effect of the synthesized compounds on different bacteria and fungal strains. The compounds 5a-n were screened for their antibacterial activity [27, 28] against human pathogenic Gram negative bacteria such as Escherichia coli MTCC442, Pseudomonas aeruginosa MTCC441 and Gram positive bacteria Staphylococcus aureus MTCC96, and Streptococcus pyogenes MTCC443. DMSO was used as diluents and Gentamycin, Ampicillin, Chloramphenicol, Ciprofloxacin and Norfloxacin as standard. The compounds 5a-n were also screened for their antifungal activity [29] against Candida albicans MTCC227, Aspergillus Niger MTCC282 and Aspergillus clavatus MTCC1323. Broth dilution method was used to evaluate the antibacterial activity. It is carried out in tubes. Mueller Hinton Broth [30] was used as nutrient medium. Serial dilutions were prepared in primary and secondary screening. Each synthesized drug was diluted obtaining 2000 μg/mL concentration, as a stock solution. In primary screening 1000, 500 and 250 μg/mL concentrations of the synthesized drugs were taken. The drugs found active in primary screening were similarly diluted to obtain 200, 100, 50, 25, 12.5, and 6.250 μg/mL, and concentrations. The highest dilution showing at least 99% inhibition zone was taken as MIC.
Results and discussion
We have synthesized a series of novel benzimidazoles; initially we have carried out the condensation of o-phenylene diamine (OPDA) (1) with 4-bromophenoxy acetic acid (2) in 4 N HCl at reflux temperature for 6 h. After simple workup gives 2-(4-bromo-phenoxymethyl)-1H-benzimidaziole (3) [22] (Scheme 1).
Having obtained compound 3, we have carried out Nalkylation to get compounds 4a-g (Scheme 1). Compounds 4a-g were then reacted phenyl boronic acid and 4-ethylphenyl boronic acid in presence of potassium fluoride, palladium acetate and 18-crown-6 under suzuki coupling condition to get compounds N-substituted 2-(biphenyl-4-yloxymethyl)-1H-benzimidazole, 2-(4'-ethyl-biphenyl-4-yloxymethyl)-1H-benzimidazole derivatives (5a-n) (Scheme 2). It is noteworthy to mention here that we have synthesized compound 3 and 5a-n alternatively by microwave irradiation in comparable yield, which give the scope of alternative route to synthesis benzimidazoles at low temperature and in less reaction time. The structures of all the synthesized compounds were characterized by spectroscopic data, and allowed these molecules for study of antibacterial and antifungal activities.
The examination of the data reveals that compounds 5a, 5c, 5d, 5g, 5h and 5k possess high activity against Escherichia coli whereas compounds 5a-n were highly active against Staphylococcus aureus and compound 5a, 5e, and 5n have also exerted very good activity against Streptococcus pyogenes employed for screening, the results are presented in Table 1 . The compounds 5a and 5h show excellent activity against Candida albicans. But rests of other compounds are not displayed significant anti-fungal activity when compared to the standard Nystatin and Greseofulvin; the results are presented in Table 2 .
Conclusion
Newly synthesized N-substituted 2-(biphenyl-4-yloxy methyl)-1H-benzimidazole, 2-(4'-ethyl-biphenyl-4-yloxymeth yl)-1H-benzimidazole derivatives by using Suzuki coupling conditions were thoroughly characterized and some of them exhibited antibacterial activity. The compounds 5a and 5h exhibited antifungal activity. However, antifungal activity of the other synthesized compounds was unsatisfactory.
